Weight Loss Medications: The 2026 Complete Guide

Weight loss medications have changed dramatically in the past five years. GLP-1 receptor agonists now produce 15–22% body weight loss in trials, far exceeding older drugs. Here is the full 2026 picture: every FDA-approved option, what it does, what it costs, and how to choose.

Last updated May 1, 2026.

Advertising disclosure: GLP Insights is reader-supported. When you book a consultation or purchase through our partner links, we may earn a commission at no additional cost to you. This does not influence which providers or medications we discuss. Learn how this site is funded.

Compare My Options

Licensed providers · All 50 states · No insurance required

✓ Updated monthly with FDA + clinical research ✓ Affiliate-supported, editorially independent ✓ Plain-English explanations of complex medical topics

Weight loss medication pharmacy overview

FDA-Approved Weight Loss Medications

Drug	Mean weight loss	Cost/month (cash)	Mechanism
Tirzepatide (Zepbound)	~22%	$1,000–1,350	Dual GIP/GLP-1 agonist
Semaglutide (Wegovy)	~15%	$1,300+	GLP-1 receptor agonist
Phentermine + topiramate (Qsymia)	~9.3%	$120–200	Sympathomimetic + anticonvulsant
Liraglutide (Saxenda)	~8.0%	$1,350	GLP-1 receptor agonist
Naltrexone + bupropion (Contrave)	~6.1%	$140–250	Opioid antagonist + antidepressant
Phentermine (alone)	~5–7%	$10–30	Sympathomimetic appetite suppressant
Orlistat (Xenical, Alli)	~3–5%	$50–80 (Rx); $30 OTC	Lipase inhibitor
Setmelanotide (Imcivree)	Specialized	$$$	MC4R agonist (rare obesity)

GLP-1 vs Older Weight Loss Medications

For most patients, GLP-1 receptor agonists now produce 2–3 times the weight loss of older medications with a generally acceptable safety profile. Older medications still have a role:

Phentermine: Cheap, short-term use, appetite suppression. Best for short bursts or as bridge therapy.
Qsymia (phentermine + topiramate): Stronger than phentermine alone; long-term use approved. Risk of cognitive side effects.
Contrave (naltrexone + bupropion): Modest effect; can help with food cravings and emotional eating.
Orlistat: Works by blocking fat absorption. Side effects (oily stools, urgency) limit adherence.

How to Choose Between Them

Insurance coverage. If your insurance covers GLP-1, that is usually the most effective option.
Cost preference. Cash-pay patients seeking maximum effect: compounded GLP-1 ($199–499/month). Cash-pay patients seeking minimum cost: phentermine ($10–30/month, smaller effect).
Medical history. Cardiovascular disease, mood disorders, thyroid history all influence which drug is appropriate.
Side-effect tolerance. GLP-1 GI symptoms vs Qsymia cognitive effects vs Contrave nausea, etc.

Talk to a Provider About Your Options

Licensed providers · All 50 states · No insurance required

Combination Approaches

Some clinicians combine medications when single-drug response is inadequate. Examples include adding phentermine in the morning to a GLP-1 maintenance dose, or using a GLP-1 plus Contrave. Combinations are off-label and require careful supervision.

What's New in 2026

Wegovy expansion for cardiovascular risk reduction (post-SELECT)
Zepbound for obstructive sleep apnea in obesity
LillyDirect self-pay Zepbound vials at $349–550/month
Pipeline: retatrutide (triple agonist), orforglipron (oral GLP-1), CagriSema, survodutide
Compounded GLP-1 availability dependent on FDA shortage status

Who Should Consider Weight Loss Medication?

FDA criteria for most weight loss medications:

BMI 30 or higher, or
BMI 27+ with at least one weight-related comorbidity (T2D, hypertension, dyslipidemia, OSA, CV disease)
Failed adequate trial of diet and exercise alone

Realistic Expectations

Medications work alongside, not instead of, dietary and lifestyle changes. Patients who pair medication with sustainable food and activity habits get the best long-term results. Patients who expect medication alone to fix obesity without any behavioral changes are often disappointed.

What About OTC "Weight Loss Pills"?

Over-the-counter weight loss supplements have very limited evidence. Most products with strong marketing claims rely on either caffeine or fiber. The only OTC weight loss drug with FDA recognition is low-dose orlistat (Alli) — with modest effect and the same side-effect profile as prescription orlistat. See our supplements page.

Frequently Asked Questions

What weight loss medications are FDA-approved in 2026? +

GLP-1s (Wegovy, Zepbound, Saxenda), older agents (phentermine, phentermine/topiramate, naltrexone/bupropion, orlistat), and Rybelsus oral semaglutide off-label. Tirzepatide-based Zepbound also has an OSA indication.

Which weight loss medication works best? +

In head-to-head and trial data, tirzepatide (Zepbound) currently shows the highest average weight loss, followed by semaglutide (Wegovy). Older medications show much smaller effects.

Does insurance cover weight loss medication? +

Coverage is inconsistent. GLP-1s are more likely covered for type 2 diabetes than weight loss alone. Always check plan formulary and prior authorization requirements.

Are weight loss medications safe long-term? +

GLP-1s have growing long-term safety data with favorable cardiovascular outcomes. Older agents have specific contraindications (e.g., phentermine and cardiovascular disease). Discuss with your provider.

Sources

FDA approved weight management drug labels.
SURMOUNT-1, STEP-1, SCALE, COR-I, CONQUER, XENDOS clinical trials.
Endocrine Society pharmacological management of obesity clinical practice guideline.